From The Editor-In-Chief
Emerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
by William G. Nelson, MD, PhD
Getting Help to Avoid Financial Distress | Cryoablation May Be a Treatment Option for Some Patients | Makers of E-Cigarettes Tout Role in Smoking Cessation | More Options to Prevent Blood Clots in High-Risk Cancer Patients | New Guidelines for Radiation Therapy in Pancreatic Cancer | Managing Opioid-Related Constipation | What’s Next
YOUR CANCER GUIDE
Patients with metastatic disease need to carefully consider risks and benefits of therapies within the context of their goals.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
When families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
Cancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
Mark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
Advocacy in Action
Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
Go With Your Gut | The ABCs of CBD
Science writer Charles Graeber describes how a shift in researchers’ understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
Experts offer advice on getting involved with patient advocacy, expressing feelings to loved ones, and hospice care.
A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.
by Elizabeth Rosto Sitko
Readers share snapshots of their lives today.
Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates.
A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials.
by Emma Yasinski
The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types.
by Anna Azvolinsky
Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker.
by Rob Weker
This genome editing system allows researchers to accurately delete, add or modify specific regions of the genome.
The leading cause of liver cancer is infection with the hepatitis B virus or the hepatitis C virus.
The passing of Alex Trebek has brought pancreatic cancer into the public consciousness.
Handle With Care
donate to the AACR